Once-Daily Orforglipron Pill Shows Promising Weight Loss and Blood Sugar Results

A recent clinical trial indicates that orforglipron, a new once-daily oral medication, achieved superior weight loss and improved blood sugar control. This drug's effectiveness surpasses that of a current leading oral semaglutide, potentially offering a more convenient alternative to existing injectable treatments for weight management.